Noninvasive Biomarkers for Early Detection of Primary Sclerosing Cholangitis in Ulcerative Colitis
Authors:
- Pedram Asadi SarabiPSPedram Asadi Sarabi
- Alireza Beheshti-MaalABAlireza Beheshti-Maal
- Amir Ali JudakiAJAmir Ali Judaki
- Seyedeh Kiana TeymoorianSTSeyedeh Kiana Teymoorian
- Zohreh HashemianZHZohreh Hashemian
- Elham RismaniERElham Rismani
- Asma GulAGAsma Gul
- Reza MalekzadehRMReza Malekzadeh
- Moustapha HassanMoustapha Hassan
- Massoud VosoughMassoud Vosough
Open Access
- 1 January 2026
- journal article
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e9547868
Abstract
Primary sclerosing cholangitis (PSC) is a progressive cholestatic liver disease strongly associated with ulcerative colitis (UC). Although uncommon, PSC‐associated ulcerative colitis (PSCUC) represents a distinct subtype of inflammatory bowel diseases characterized by a higher risk of colorectal and hepatobiliary cancers. Early diagnosis remains a challenging issue because of the lack of specific biomarkers. Bioinformatic analysis of Gene Expression Omnibus (GEO) datasets identified potential, specific, and noninvasive biomarkers via differential gene expression and functional enrichment. After processing the data, S100A8 and S100A12 were identified as candidate biomarkers for detecting PSC in patients with UC. S100A8 encodes one component of calprotectin, the S100A8/S100A9 heterodimer widely used as a marker of intestinal inflammation. These two genes are primarily involved in inflammation, immune responses, and leukocyte recruitment, making them potentially useful biomarkers for early detection in PSC in UC patients. These biomarkers offer potential implications for disease stratification and therapeutic targeting. Further validation in prospective clinical studies is warranted to confirm their diagnostic and prognostic utilities.Keywords
This publication has 46 references indexed in Scilit:
- Ulcerative Colitis in AdultsJAMA, 2023
- Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitisInternational Journal of Colorectal Disease, 2023
- Bioinformatic Methods and Resources for Biomarker Discovery, Validation, Development, and Integration2018
- IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitisBiomedicine & Pharmacotherapy, 2018
- Global microRNA expression profiling in the liver biopsies of hepatitis B virus–infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injuryHepatology, 2018
- Magnetic resonance cholangiopancreatography: the ABC of MRCPInsights into Imaging, 2011
- Incidence of primary sclerosing cholangitis: A systematic review and meta-analysisHepatology, 2011
- Diagnosis and Management of Primary Sclerosing CholangitisHepatology, 2010
- Human S100A12: a novel key player in inflammation?Amino Acids, 2008
- Primary sclerosing cholangitisHepatology, 1999